| Breakdown | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 897.90M | 898.60M | 872.30M | 799.60M | 401.70M |
| Gross Profit | 509.90M | 489.10M | 435.70M | 335.40M | 74.20M |
| EBITDA | 223.50M | 166.20M | 115.30M | 296.20M | -34.20M |
| Net Income | 71.60M | -18.50M | -9.30M | 137.20M | -127.70M |
Balance Sheet | |||||
| Total Assets | 2.32B | 2.21B | 2.45B | 2.52B | 2.47B |
| Cash, Cash Equivalents and Short-Term Investments | 35.90M | 45.50M | 29.60M | 30.70M | 35.40M |
| Total Debt | 1.24B | 1.30B | 1.60B | 1.62B | 1.64B |
| Total Liabilities | 1.53B | 1.56B | 1.81B | 1.87B | 2.06B |
| Stockholders Equity | 790.70M | 654.80M | 640.10M | 648.10M | 406.40M |
Cash Flow | |||||
| Free Cash Flow | 138.00M | 161.20M | 75.90M | -14.60M | -107.70M |
| Operating Cash Flow | 199.20M | 207.40M | 141.20M | 55.50M | -61.10M |
| Investing Cash Flow | -54.20M | 211.90M | -9.80M | -29.10M | 197.70M |
| Financing Cash Flow | -154.60M | -401.40M | -132.60M | -30.90M | -145.10M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | £356.19M | 17.87 | 4.99% | 2.81% | 6.94% | 9.13% | |
66 Neutral | £303.77M | 4.07 | 9.30% | ― | -0.52% | 68.53% | |
65 Neutral | £1.39B | 7.62 | 6.41% | ― | 2.96% | 9.30% | |
64 Neutral | £303.77M | 4.07 | 9.75% | ― | ― | ― | |
63 Neutral | £455.31M | 17.37 | 3.55% | 3.20% | 4.61% | 186.76% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
55 Neutral | £634.88M | 11.98 | 15.81% | 1.50% | 5.39% | -3.64% |